{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:16Z","timestamp":1787772436525,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"\n Background:<\/jats:title>\n Chronic dermatophytosis refers to persistent or recurrent episodes of dermatophytosis lasting for more than 1 year despite adequate treatment with topical and systemic antifungal agents. The rise in the number of these cases is alarming over the past 5 to 6 years, and a thorough knowledge about the reasons for chronicity of dermatophytosis may go a long way in the treatment and prevention of this infection.<\/jats:p>\n <\/jats:sec>\n \n Aims and Objectives:<\/jats:title>\n The aim of this study was to investigate the epidemiology, various clinical types, and factors associated with chronicity in patients with chronic dermatophytosis, and to isolate the etiological agents and study the clinicomycological correlation.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n Detailed history and clinical details of all patients with chronic dermatophytosis who presented to our tertiary care center over a span of 1 year were recorded. Skin scrapings from these patients were subjected to potassium hydroxide mount and culture in modified Sabouraud's dextrose agar medium.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Sixty-four patients were enrolled in this study with a mean age of 44.5 years. The mean duration of infection was 3.14 years. Tinea corporis was the most common clinical type seen in 46 (71.9%) patients, affecting commonly the waist area in females and the back in males. Bronchial asthma was the most frequent systemic association affecting 20 (31.3%) patients followed by diabetes mellitus, which was present in 13 (20.3%) patients. About 34% patients had a history of long-term steroid use. Among the 28 isolates,\n Trichophyton mentagrophytes<\/jats:italic>\n was the most frequent species isolated (46.4%), followed by\n Trichophyton rubrum<\/jats:italic>\n (39.3%).\n Trichophyton tonsurans<\/jats:italic>\n and\n Trichophyton verrucosum<\/jats:italic>\n were isolated from two patients each.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n \n Extensive area of involvement, atopy, diabetes, and long-term use of systemic corticosteroids were associated with chronicity. Unlike in the yesteryears,\n T. mentagrophytes<\/jats:italic>\n has emerged as the most common etiological agent of chronic dermatophytosis.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijd.ijd_539_20","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:21:06Z","timestamp":1716985266000},"page":"445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiological Trends and Clinicomycological Profile of Chronic Dermatophytosis"],"prefix":"10.4103","volume":"66","author":[{"given":"Remya","family":"Rajamohanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Chellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Rengasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20240829","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2340\/0001555558139143","article-title":"The clinical significance of cutaneous reactions to trichophytin in dermatophytosis","volume":"58","author":"Kaaman","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"R2-31-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1982.tb00895.x","article-title":"Chronic dermatophytic infections. I. Clinical and mycological features","volume":"106","author":"Hay","year":"1982","journal-title":"Br J Dermatology"},{"key":"R3-31-20240829","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"R4-31-20240829","first-page":"129","article-title":"Scenario of chronic dermatophytosis: An Indian study","volume":"140","author":"Sentamilselvi","year":"1998","journal-title":"Mycopathologia 1997"},{"key":"R5-31-20240829","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/2229-5178.178100","article-title":"The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive?","volume":"7","author":"Dogra","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"R6-31-20240829","first-page":"128","article-title":"Menace of chronic dermatophytosis - A descriptive study in a tertiary care center","volume":"7","author":"Jamuna","year":"2019","journal-title":"J Med Sci Clin Res"},{"key":"R7-31-20240829","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.18410\/jebmh\/2017\/568","article-title":"Clinical profile of patients with chronic dermatophytosis- A descriptive study from a tertiary care centre in Kerala","volume":"4","author":"Zacharia","year":"2017","journal-title":"J Evid Based Med Healthc"},{"key":"R8-31-20240829","first-page":"551","article-title":"A clinico-mycological study of chronic dermatophytosis of more than years duration","volume":"5","author":"Karthika","year":"2016","journal-title":"Int J Sci Res"},{"key":"R9-31-20240829","first-page":"40","article-title":"Immediate hypersensitivity and serum IgE antibody responses in patients with dermatophytosis","volume":"30","author":"Khosravi","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R10-31-20240829","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0378-6323.14003","article-title":"A study of chronic dermatophyte infection in a rural hospital","volume":"71","author":"Prasad","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R11-31-20240829","first-page":"19","article-title":"Epidemiology and clinical features of dermatomycosis and dermatophytosis","volume":"121","author":"Svejgaard","year":"1986","journal-title":"Acta Derm Venereol Suppl (Stockh"},{"key":"R12-31-20240829","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000051668","article-title":"Asthma, rhinitis and dermatitis triggered by fungal infections: Therapeutic effects of terbinafine","volume":"202","author":"Hurlimann","year":"2001","journal-title":"Dermatology"},{"key":"R13-31-20240829","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0190-9622(92)70063-L","article-title":"Prevalence of dermatophytosis in patients with diabetes","volume":"26","author":"Lugo-Somolinos","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R14-31-20240829","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2133.1996.tb06322.x","article-title":"The prevalence of dermatophytosis infection in well controlled diabetics and the responseto trichophyton antigen","volume":"134","author":"Buxton","year":"1996","journal-title":"Br J Dermatol"},{"key":"R15-31-20240829","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1439-0507.2001.00624.x","article-title":"Prevalence of dermatophytic skin and nail infection in diabetic patients","volume":"44","author":"Romaro","year":"2001","journal-title":"Mycoses"},{"key":"R16-31-20240829","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archderm.1991.01680020137024","article-title":"Generalised chronic dermatophytosis in patients with human immunodeficiency virus Type 1 infection and CD4 depletion","volume":"127","author":"Wright","year":"1991","journal-title":"Arch Dermatol"},{"key":"R17-31-20240829","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mjd.2003.327","article-title":"Tinea Capitis in adult women masquerading as bacterial pyoderma","volume":"49","author":"Martin","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R18-31-20240829","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(89)92863-8","article-title":"Trichophyton asthma: Sensitisation of bronchi and upper airways to dermatophyte antigen","volume":"1","author":"Ward","year":"1989","journal-title":"Lancet"},{"key":"R19-31-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/CDR.CDR_36_17","article-title":"Systemic therapy of dermatophytosis: Practical and systematic approach","volume":"1","author":"Rengasamy","year":"2017","journal-title":"Clin Dermatol Rev"},{"key":"R20-31-20240829","doi-asserted-by":"crossref","first-page":"e01038","DOI":"10.1128\/AAC.01038-18","article-title":"Correlation of in vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis\/cruris?","volume":"62","author":"Khurana","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_539_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:42Z","timestamp":1787770002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_539_20"}},"subtitle":["A Descriptive Study From South India"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_539_20","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}